NCT01053858

Triamcinolone or Bevacizumab for Central Retinal Vein Occlusion With Poor Vision

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 38 (actual)
• Sponsor: Hallym University Medical Center · Academic / Other
• Sex: All
• Age: 20 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the effect of intravitreal bevacizumab with intravitreal triamcinolone for the treatment of central retinal vein occlusion (CRVO) presenting poor visual acuity.

Conditions

• Central Retinal Vein Occlusion With 20/200 or Worse Visual Acuity

Interventions

Type	Name	Description
PROCEDURE	intravitreal injection	intravitreal bevacizumab( 1.25 mg) or triamcinolone( 4mg) injection

Timeline

• Start date: 2008-01-01
• Primary completion: 2009-01-01
• Completion: 2010-01-01
• First posted: 2010-01-22
• Last updated: 2010-01-22

Locations

1 site across 1 country: South Korea